# CHRNB3

## Overview
The CHRNB3 gene encodes the cholinergic receptor nicotinic beta 3 subunit, a component of the nicotinic acetylcholine receptors (nAChRs), which are classified as ligand-gated ion channels. These receptors are integral to neurotransmission, facilitating ion flow across cell membranes upon activation by acetylcholine. The beta 3 subunit, while not directly involved in ligand binding, is essential for the structural integrity and pharmacological characteristics of the receptor, influencing its functional properties (Kamens2015The). The expression of the β3 subunit is predominantly observed in brain regions associated with dopaminergic signaling, such as the substantia nigra and ventral tegmental area, implicating it in the modulation of behaviors linked to dopamine, including nicotine consumption and locomotor activity (Cui2003The; Kamens2015The). The gene's clinical relevance is underscored by its association with nicotine dependence and Parkinson's disease, highlighting its potential as a target for therapeutic interventions (Wen2017Significant; BarShira2014CHRNB3).

## Function
The CHRNB3 gene encodes the beta-3 (β3) subunit of nicotinic acetylcholine receptors (nAChRs), which are pentameric ligand-gated ion channels involved in neurotransmission. These receptors are activated by the neurotransmitter acetylcholine, leading to the flow of ions across the cell membrane, which influences neuronal excitability and synaptic plasticity. The β3 subunit is not directly involved in ligand binding but plays a crucial role in the structural conformation and pharmacological properties of the receptor, affecting its function (Kamens2015The).

The β3 subunit is expressed in specific brain regions, including the substantia nigra, ventral tegmental area, and medial habenula, which are important for modulating dopaminergic signaling. This subunit is a component of α-conotoxin MII-binding nAChRs, which are involved in dopamine release from dopaminergic terminals, particularly in the striatum (Cui2003The; Kamens2015The). The presence of the β3 subunit in these receptors is associated with the modulation of behaviors related to dopamine, such as locomotor activity and nicotine consumption (Cui2003The; Kamens2015The). The β3 subunit's role in these processes highlights its importance in the central nervous system's function and its potential influence on addiction pathways.

## Clinical Significance
Mutations and alterations in the CHRNB3 gene have been associated with several clinical conditions, most notably nicotine dependence and Parkinson's disease. The CHRNB3-CHRNA6 gene cluster has been significantly linked to nicotine dependence, particularly in the Chinese Han population. Studies have identified specific single nucleotide polymorphisms (SNPs) within this cluster, such as rs6474414, that show strong associations with nicotine dependence as measured by the Fagerström Test for Nicotine Dependence (FTND) (Wen2017Significant). These genetic variations are thought to influence the function of nicotinic acetylcholine receptors, which play a critical role in nicotine addiction (Wen2016Crucial).

In Parkinson's disease, the c.-57A>G alteration in the CHRNB3 promoter region has been associated with an increased risk of the disease. This alteration affects the binding of transcription factors, reducing promoter activity and potentially influencing gene expression. The c.-57G allele is more frequent in Parkinson's patients and is linked to smoking behavior, suggesting a complex interaction between genetic predisposition and environmental factors like smoking (BarShira2014CHRNB3). These findings highlight the role of CHRNB3 in both nicotine dependence and Parkinson's disease, underscoring its clinical significance.


## References


[1. (Wen2016Crucial) L Wen, Z Yang, W Cui, and M D Li. Crucial roles of the chrnb3–chrna6 gene cluster on chromosome 8 in nicotine dependence: update and subjects for future research. Translational Psychiatry, 6(6):e843–e843, June 2016. URL: http://dx.doi.org/10.1038/tp.2016.103, doi:10.1038/tp.2016.103. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/tp.2016.103)

[2. (BarShira2014CHRNB3) Anat Bar-Shira, Mali Gana-Weisz, Ziv Gan-Or, Eytan Giladi, Nir Giladi, and Avi Orr-Urtreger. Chrnb3 c.-57a&gt;g functional promoter change affects parkinson’s disease and smoking. Neurobiology of Aging, 35(9):2179.e1-2179.e6, September 2014. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2014.03.014, doi:10.1016/j.neurobiolaging.2014.03.014. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neurobiolaging.2014.03.014)

[3. (Cui2003The) Changhai Cui, T. K. Booker, Roberta S. Allen, Sharon R. Grady, Paul Whiteaker, Michael J. Marks, Outi Salminen, Theresa Tritto, Christopher M. Butt, W. R. Allen, Jerry A. Stitzel, J. Michael McIntosh, Jim Boulter, Allan C. Collins, and Stephen F. Heinemann. The β3 nicotinic receptor subunit: a component of α-conotoxin mii-binding nicotinic acetylcholine receptors that modulate dopamine release and related behaviors. The Journal of Neuroscience, 23(35):11045–11053, December 2003. URL: http://dx.doi.org/10.1523/jneurosci.23-35-11045.2003, doi:10.1523/jneurosci.23-35-11045.2003. This article has 183 citations.](https://doi.org/10.1523/jneurosci.23-35-11045.2003)

[4. (Kamens2015The) Helen M. Kamens, Jill Miyamoto, Matthew S. Powers, Kasey Ro, Marissa Soto, Ryan Cox, Jerry A. Stitzel, and Marissa A. Ehringer. The β3 subunit of the nicotinic acetylcholine receptor: modulation of gene expression and nicotine consumption. Neuropharmacology, 99:639–649, December 2015. URL: http://dx.doi.org/10.1016/j.neuropharm.2015.08.035, doi:10.1016/j.neuropharm.2015.08.035. This article has 17 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.neuropharm.2015.08.035)

[5. (Wen2017Significant) Li Wen, Haijun Han, Qiang Liu, Kunkai Su, Zhongli Yang, Wenyan Cui, Wenji Yuan, Yunlong Ma, Rongli Fan, Jiali Chen, Keran Jiang, Xianzhong Jiang, Thomas J. Payne, Jundong Wang, and Ming D. Li. Significant association of the chrnb3-chrna6 gene cluster with nicotine dependence in the chinese han population. Scientific Reports, August 2017. URL: http://dx.doi.org/10.1038/s41598-017-09492-8, doi:10.1038/s41598-017-09492-8. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-09492-8)